Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication.

Antimicrobial agents and chemotherapy - 1 Sept 2011

Delang Leen, Vliegen Inge, Froeyen Mathy, Neyts Johan

Abstract excerpt

Hepatitis C virus (HCV) inhibitors include direct-acting antivirals (DAAs) such as NS3 serine protease inhibitors, nucleoside and nonnucleoside polymerase inhibitors, and host-targeting antivirals (HTAs) such as cyclophilin inhibitors that have been developed in recent years. Drug-resistant HCV v...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbamates
Share to Drug Resistance, Viral
Share to Macrocyclic Compounds

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oligopeptides

Share to Quinolines

Share to Replicon

Share to Thiazoles

Share to Virus Replication

Source

Open in PubMed Open full text

Identifiers

PMID: 21709100
DOI: 10.1128/AAC.00294-11
PMCID: PMC3165355

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21709100-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication.PMID 21709100Read ↗

The emerging field of HCV drug resistanceSemantic proximity Read ↗

Resistance to direct antiviral agents in patients with hepatitis C virus infection.Semantic proximity Read ↗

Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro.Semantic proximity Read ↗

Preexisting drug-resistance mutations reveal unique barriers to resistance for distinct antivirals.Semantic proximity Read ↗

Hepatitis C virus resistance to protease inhibitors.Semantic proximity Read ↗

Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system.Semantic proximity Read ↗

Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis CSemantic proximity Read ↗

Update on hepatitis C virus resistance to direct-acting antiviral agents.Semantic proximity Read ↗

Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro.Semantic proximity Read ↗

Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?Semantic proximity Read ↗

The role of resistance in HCV treatment.Semantic proximity Read ↗

Studies on hepatitis C virus resistance to inhibitors in replicon systems.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.